Lantheus (LNTH) is down -33.1%, or -$24.02 to $48.62.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Lantheus Announces FDA Acceptance of New Drug Application
- Lantheus lowers FY25 adjusted EPS view $5.50-$5.70 from $6.60-$6.70
- Lantheus reports Q2 adjusted EPS $1.57, consensus $1.68
- Lantheus board authorizes $400M stock repurchase plan
- Lantheus announces FDA acceptance of NDA for PSMA PET formulation